Patents by Inventor Andrew C. Peterson
Andrew C. Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6289317Abstract: A task-based classification and analysis system includes an analysis software module and a user interface. The analysis software module establishes and maintains relationships between a plurality of databases or, in a preferred embodiment, hierarchical task lists. The user interface provides user inputs to the analysis software module such as budget information which is associated with particular elements of the databases. In consideration of historical data models, the user inputs and predetermined relationships between elements of the databases, the preferred system generates information products such as task-based budgets. Another preferred system coordinates task relationships between a plurality of software modules, such as a billing software module and a time entry software module.Type: GrantFiled: March 9, 2000Date of Patent: September 11, 2001Assignee: Paul Hastings, Janofsky & WalkerInventor: Andrew C. Peterson
-
Patent number: 6177476Abstract: A method of replenishing plasmalogens in mammals comprising treatment with a plasmalogen-replenishing-effective amount of one or more stantially pure monoethers of glycerols and their carboxylic acid ester derivatives of Formula I: wherein R is a C12-C22 linear or branched alkyl or alkenyl group; and R1 and R2 are, each independently, hydrogen or an acyl moiety {—C(═O)—R3} wherein R3 is a linear or branched C1-C30 alkyl or alkenyl; and pharmaceutically-acceptable salts thereof, is disclosed. Nutritional supplements, dietary supplements and food additives comprising one or more substantially pure compounds of Formula I is also disclosed.Type: GrantFiled: August 27, 1998Date of Patent: January 23, 2001Assignee: Clarion Pharmaceuticals Inc.Inventors: Andrew C. Peterson, Thaddeus P. Pruss
-
Patent number: 6073108Abstract: A task-based classification and analysis system includes an analysis software module and a user interface. The analysis software module establishes and maintains relationships between a plurality of databases or, in a preferred embodiment, hierarchical task lists. The user interface provides user inputs to the analysis software module such as budget information which is associated with particular elements of the databases. In consideration of historical data models, the user inputs and predetermined relationships between elements of the databases, the preferred system generates information products such as task-based budgets. Another preferred system coordinates task relationships between a plurality of software modules, such as a billing software module and a time entry software module.Type: GrantFiled: June 21, 1996Date of Patent: June 6, 2000Assignee: Paul, Hastings, Janofsky & WalkerInventor: Andrew C. Peterson
-
Patent number: 5972982Abstract: Heteroaryl-substituted deoxy glycerols represented by the general Formulas Ia, Ib and Ic: ##STR1## wherein: X is oxygen (--O--) or sulfur (--S--); R is substituted or unsubstituted straight or branched chain C.sub.1-30 alkyl or alkenyl, provided that a double bond of the alkenyl does not originate at the carbon atom bound to the X substituent; Het is a 5- to 9-membered heteroaryl mono- or bicyclic ring system having no more than 1 carbonyl carbon in the ring system, with 1 to 4 nitrogen atoms as the sole heteroatoms, one of which nitrogens is bonded to the glycero carbon; and Y is hydroxyl (--OH) or thiol (--SH), pharmaceutical compositions containing the same, and methods of using the compounds, are disclosed. The compounds exhibit antiviral and antibacterial activities.Type: GrantFiled: October 7, 1997Date of Patent: October 26, 1999Assignee: Clarion Pharmaceuticals Inc.Inventors: Haridasan K. Nair, Andrew C. Peterson, Friedrich Paltauf, Albin Hermetter, Rudolf Franzmair
-
Patent number: 5891881Abstract: Aminoheterocycle-substituted glycerols of Formula I are disclosed: ##STR1## wherein one of A, B or C is --X--R, wherein X is --O-- or --S--, and R is a substituted or unsubstituted C.sub.12-24 alkyl or alkenyl, the substituent being one or more of halo, C.sub.1-3 alkoxy or cyano, provided that a double bond of the alkenyl does not originate at the carbon atom bound to X; and another of A, B or C is an aminoheterocycle ring substituent --Het--NH.sub.2, wherein Het is a 5 to 11-membered monocyclic, bicyclic or bicyclic fused heterocyclic ring moiety with at least 1 to 4 nitrogens atoms contained within the hetero cyclic moiety, one of which nitrogen atoms is bonded to the glycero carbon; and the remaining A, B, or C substituent is --OH. The compounds of Formula I, isomers, salts, pharmaceutical compositions and appliances incorporating the same, and methods of use thereof are also disclosed.Type: GrantFiled: November 21, 1997Date of Patent: April 6, 1999Assignee: Clarion Pharmaceuticals Inc.Inventors: Haridasan K. Nair, Andrew C. Peterson
-
Patent number: 5883084Abstract: Disclosed is a method of treating respiratory diseases comprising treating the lungs with an therapeutically-effective amount of .alpha.-tocopheryl-phosphocholine or a pharmaceutically-acceptable salt thereof, wherein the amount is administered is effective to make breathing easier.Type: GrantFiled: June 8, 1998Date of Patent: March 16, 1999Assignee: Clarion Pharmaceuticals Inc.Inventors: Andrew C. Peterson, Thaddeus P. Pruss
-
Patent number: 5827836Abstract: Retinoyl substituted glycerophosphoethanolamines are disclosed having the general Formula I: ##STR1## wherein one of A, B or C is a fatty ether substituent, one is a natural or synthetic retinoid ester substituent, and one is a phosphoethanolamine substituent, provided that A, B and C are each a different substituent. The optical and geometric isomers of compounds of Formula I and the pharmaceutically acceptable salts of the compounds, including the isomers, are also disclosed. The compounds (including the isomers thereof) and salts of the invention exhibit anti-tumor, anti-psoriatic and anti-inflammatory activities.Type: GrantFiled: November 15, 1996Date of Patent: October 27, 1998Assignee: Clarion Pharmaceuticals Inc.Inventors: Andrew C. Peterson, Thaddeus P. Pruss, Parvin T. Yazdi
-
Patent number: 5804569Abstract: Disclosed are the use of certain cycloalkyl- and aryl-phosphoethanolamines as anti-inflammatory, anti-arrhythmic and local anesthetic agents. These therapeutically active cycloalkyl- and aryl-phosphoethanolamines are of the general Formula I:R--O--PEA Iwherein R is an unsubstituted or a substituted C.sub.5-7 cycloalkyl or an unsubstituted or a substituted phenyl in which each substituent is hydrogen or an unsubstituted or substituted straight or branched C.sub.1-4 alkyl or C.sub.2-4 alkenyl, said substitution being one or more of C.sub.1-4 alkoxy, halo or cyano; and --O--PEA represents a phosphoethanolamine substituent. Also disclosed are intermediates for producing Formula I compounds.Type: GrantFiled: March 14, 1997Date of Patent: September 8, 1998Assignee: Clarion Pharmaceuticals Inc.Inventors: Andrew C. Peterson, Haridasan K. Nair
-
Patent number: 5776915Abstract: Novel retinoid phosphocholines are disclosed having the general Formula (I): ##STR1## wherein R represents a retinyl or retinoyl moiety. The optical and geometric isomers of compounds of Formula (I) and the pharmaceutically-acceptable salts thereof, are also disclosed. The subject compounds exhibit anti-tumor, anti-psoriatic and anti-inflammatory activities in addition to their inherent Vitamin A-like activities. The invention embraces the novel compounds, pharmaceutical compositions thereof, and methods of using the same.Type: GrantFiled: August 12, 1997Date of Patent: July 7, 1998Assignee: Clarion Pharmaceuticals Inc.Inventors: Andrew C. Peterson, Haridasan K. Nair
-
Patent number: 5691328Abstract: Certain phosphoethanolamine conjugates of vitamin D compounds are disclosed wherein the phosphoethanolamine moiety is bonded at the 3-position of the vitamin D moiety. The conjugates exhibit anti-tumor, anti-psoriatic and anti-inflammatory activities in addition to those activities associated with vitamin D. The invention embraces the novel compounds, pharmaceutical compositions thereof, and their methods of use.Type: GrantFiled: August 27, 1996Date of Patent: November 25, 1997Assignee: Clarion Pharmaceuticals Inc.Inventors: Andrew C. Peterson, Parvin T. Yazdi
-
Patent number: 5661138Abstract: Novel (o-acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines and pharmaceutically acceptable salts thereof having anti-inflammatory activity, and pharmaceutical compositions containing same are disclosed. Certain novel intermediates are also disclosed.Type: GrantFiled: October 3, 1996Date of Patent: August 26, 1997Assignee: Clarion Pharmaceutical, Inc.Inventors: Andrew C. Peterson, Rudolf Franzmair, Haridasan K. Nair